Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea

Completed

• Conditions: Dyslipidemia

• Registration Number: NCT01372956
• Lead Sponsor: AstraZeneca

Brief Summary

This is a multi-centre, cross-sectional, chart review study to investigate cholesterol goal attainment rates defined by modified NCEP-ATP III guidelines and define its possible determinants among Korean dyslipidemic patients

Detailed Description

MC MD

Study Timeline

• Study First Submitted: 2011-06-07
• Study First Submitted QC: 2011-06-13
• Study First Posted: 2011-06-14
• Study Start: 2011-08
• Primary Completion: 2011-10
• Study Completion: 2011-10
• Status Verified: 2011-12
• Last Update Submitted: 2011-12-21
• Last Update Posted: 2011-12-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 4950

Inclusion Criteria

• Patient who has a dyslipidemia with a lipid profile result within 3 months
• Patient who has a dyslipidemia without change of lipid lowering drug dosage during 3 months after lipid profile test.

Exclusion Criteria

• Patient who involved in this study previously.
• Patient who participated in other clinical study with study drug within 90 days.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cholesterol goal attainment rate according to NCEP-ATP III guideline	Once, at enrollment

Secondary Outcome Measures

Name	Time	Method
Factors for cholesterol goal achievement: Age, Family history, smoking history, waist circumstance, etc.	Once, at enrollment
Cholesterol goal attainment rate related to CHD or disease history	Once, at enrollment

Trial Locations

Locations (1)

Research Site; 🇰🇷 Seoul, Korea, Republic of